LEADER 01813oam  2200541   450 
001 9910717170903321
005 20220218093003.0
035   $a(CKB)5470000002528505
035   $a(OCoLC)1274035214$z(OCoLC)1246246255
035   $a(OCoLC)995470000002528505
035   $a(EXLCZ)995470000002528505
100   $a20210621d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdacontent
183   $acr$2rdacarrier
200 10$aCOVID-19 $eefforts to increase vaccine availability and perspectives on initial implementation: report to congressional addressees
210  1$aWashington, DC :$cUnited States Government Accountability Office,$d2021.
215   $a1 online resource (ii, 48 pages) $cillustrations
300   $a"April 2021."
300   $a"GAO-21-443."
320   $aIncludes bibliographical references.
517   $aCOVID-19 
606   $aCOVID-19 (Disease)$xVaccination$zUnited States
606   $aCOVID-19 (Disease)$xTreatment$zUnited States
606   $aVaccination$zUnited States$xPlanning
606   $aVaccination$xGovernment policy$zUnited States
606   $aPublic health administration$zUnited States
606   $aEmergency management$xEvaluation$2fast
607   $aUnited States$2fast
615  0$aCOVID-19 (Disease)$xVaccination
615  0$aCOVID-19 (Disease)$xTreatment
615  0$aVaccination$xPlanning.
615  0$aVaccination$xGovernment policy
615  0$aPublic health administration
615  7$aEmergency management$xEvaluation.
801  0$bS2H
801  1$bS2H
801  2$bDID
801  2$bOCLCF
801  2$bGPO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910717170903321
996   $aCOVID-19$92802534
997   $aUNINA